SUBCELLULAR-LOCALIZATION OF CYTOCHROME-P450, AND ACTIVITIES OF SEVERAL ENZYMES RESPONSIBLE FOR DRUG-METABOLISM IN THE HUMAN BRAIN

被引:90
作者
GHERSIEGEA, JF
PERRIN, R
LEININGERMULLER, B
GRASSIOT, MC
JEANDEL, C
FLOQUET, J
CUNY, G
SIEST, G
MINN, A
机构
[1] CHU NANCY BRABOIS,SERV ANAT PATHOL,F-54500 VANDOEUVRE NANCY,FRANCE
[2] CHU NANCY BRABOIS,SERV MED B,F-54500 VANDOEUVRE NANCY,FRANCE
关键词
D O I
10.1016/0006-2952(93)90139-N
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We studied the subcellular distribution of cytochrome P450 and related monooxygenase activities in six regions of human brains removed at autopsy. The content of total cytochrome P450 was found to be at least nine times higher in the mitochondrial fraction than in the microsomes in all the regions studied. However, cytochrome P450-dependent enzymatic activities which are representative of different isoforms metabolizing exogenous molecules exhibited a microsomal prevalence, a situation previously observed in rat brain. The other drug-metabolizing enzymes catalysing functionalization and conjugation reactions, presented the following characteristics in human brain: (i) a low activity of NADPH-cytochrome P450 reductase, which also catalyses the reduction of some xenobiotics; (ii) a high specific activity of the membrane-bound epoxide hydrolase; (iii) among the enzymes catalysing conjugation reactions, 1-naphthol-UDP-glucuronosyltransferase activity was barely or not detectable, whereas the mean glutathione-S-transferase activity was 15 times higher than the activity measured in rat brain. The presence of several drug-metabolizing enzyme activities in human brain microvessels, and particularly the high activity of epoxide hydrolase, suggests a participation of these enzymes in the metabolic blood-brain barrier.
引用
收藏
页码:647 / 658
页数:12
相关论文
共 44 条
  • [1] CHARACTERIZATION AND LOCALIZATION OF GLUTATHIONE-S-TRANSFERASES IN RAT-BRAIN AND BINDING OF HORMONES, NEUROTRANSMITTERS, AND DRUGS
    ABRAMOVITZ, M
    HOMMA, H
    ISHIGAKI, S
    TANSEY, F
    CAMMER, W
    LISTOWSKY, I
    [J]. JOURNAL OF NEUROCHEMISTRY, 1988, 50 (01) : 50 - 57
  • [2] BAARS AJ, 1980, ANN BIOL CLIN-PARIS, V38, P49
  • [3] BEND JR, 1984, DRUG METABOLISM DRUG, P99
  • [4] BENFORD DJ, 1986, PROG DRUG METAB, V9, P53
  • [5] ETHOXYPHENOXAZONES, PENTOXYPHENOXAZONES, AND BENZYLOXYPHENOXAZONES AND HOMOLOGS - A SERIES OF SUBSTRATES TO DISTINGUISH BETWEEN DIFFERENT INDUCED CYTOCHROMES-P-450
    BURKE, MD
    THOMPSON, S
    ELCOMBE, CR
    HALPERT, J
    HAAPARANTA, T
    MAYER, RT
    [J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (18) : 3337 - 3345
  • [6] BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
  • [7] COUGHTRIE MWH, 1988, MOL PHARMACOL, V34, P729
  • [8] DAILEY HA, 1980, J BIOL CHEM, V255, P5184
  • [9] CONTINUOUS FLUOROMETRIC ASSAY OF EPOXIDE HYDRASE ACTIVITY
    DANSETTE, PM
    DUBOIS, GC
    JERINA, DM
    [J]. ANALYTICAL BIOCHEMISTRY, 1979, 97 (02) : 340 - 345
  • [10] ARYL-HYDROCARBON HYDROXYLASE OF RAT-BRAIN MITOCHONDRIA - PROPERTIES OF, AND EFFECT OF INHIBITORS AND INDUCERS ON, ENZYME-ACTIVITY
    DAS, M
    SETH, PK
    DIXIT, R
    MUKHTAR, H
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1982, 217 (01) : 205 - 215